Amgen Inc. (AMGN) يقدّم في 2026 مؤتمر السociety for Medical Oncology (ESMO) السنوي

Amgen Inc. presented at the 2026 European Society for Medical Oncology Annual Congress, highlighting their recent advancements in medical oncology. The company's presentation included discussions on various topics, including their latest research and developments. Amgen Inc. is a leading biotechnology company, and their presentation at the congress is a significant event in the medical oncology field. The company's stock may be affected by the presentation, as investors closely watch the company's progress. Amgen Inc.'s developments in medical oncology have the potential to impact the entire industry. The presentation also demonstrates the company's commitment to advancing medical research and treatments.